3658 results for «391»
3658 results
Optimised patient selection for carotid artery stenting
22 May 2025 – From EuroPCR 2025
Optimize patient selection for carotid artery stenting with this session that highlights personalized approaches to ischaemic stroke treatment. Review bioactive stents versus endovascular therapy, feasibility and outcomes in near-occlusion cases, and long-term retrospective analyses supporting carotid stenting as a strategic ally in embolic stroke management.
LAA closure in challenging scenarios
22 May 2025 – From EuroPCR 2025
This session addresses the complexities of left atrial appendage (LAA) closure in challenging anatomical and clinical scenarios. Learn from compelling cases including management of incomplete surgical LAA ligation, closure of large and complex peridevice leaks, and navigating difficult anatomy in elderly patients. Emphasizing innovative techniques and...
Contemporary outcomes of PCI patients
22 May 2025 – From EuroPCR 2025
Examine contemporary outcomes in PCI patients through a collection of studies addressing angiographic complication incidences, safety of same-day discharge post-complex PCI, age-related outcome impacts in TAVI patients, and comparative long-term antiplatelet strategies. The session also explores timing effects in routine versus off-hours PCI.
Anatomy, physiology and clinical judgment: insights from contemporary strategies to guide PCI
22 May 2025 – From EuroPCR 2025
Discover contemporary strategies integrating anatomy, physiology, and clinical judgment to guide percutaneous coronary intervention (PCI). This session explores the impact of stress cardiovascular magnetic resonance in primary prevention, viability-guided PCI, and physiology-based decision-making including quantitative flow ratio (QFR). Learn about identifying patients at risk for major...
Updates on percutaneous treatment of pulmonary embolism
22 May 2025 – From EuroPCR 2025
Stay abreast of the latest advances in percutaneous treatment of pulmonary embolism. This session covers clinical outcomes with novel vacuum thrombectomy devices, mechanical thrombectomy registries, catheter-directed therapies in intermediate-high risk PE, and profiles of subacute PE interventions to inform optimal treatment strategies.
DCB in STEMI : why, when and how ?
22 May 2025 – From EuroPCR 2025
Explore the evolving role of drug-coated balloons (DCB) in the management of STEMI patients. This session covers practical approaches including primary PCI with DEB, unconventional solutions in urgent scenarios, and personalized treatment strategies especially in very young patients. Learn how DCB technology intersects with complex lesion...
Percutaneous aortic interventions: mastering the complexity
22 May 2025 – From EuroPCR 2025
Master complex percutaneous aortic interventions in this detailed session. Topics include managing life-threatening complications, percutaneous repair of ascending aortic graft pseudoaneurysms, aortic stenting for total occlusions, and troubleshooting endovascular aortic repair failures, providing a comprehensive overview of challenging aortic cases.
Acute complications during distal left main PCI - Part 1
22 May 2025 – From EuroPCR 2025
Navigate the challenges of acute complications during distal left main PCI with expert guidance. This session discusses troubleshooting techniques for stuck IVUS catheters, stepwise ostial LAD stenting, OCT applications when crush and kiss techniques fail, management of lost stents in heavily calcified bifurcations, and responses to...
3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications
22 Mar 2022
Ali Nazmi Calik provides his take on the long-term results of the SPYRAL HTN-ON MED trial which demonstrated the durable efficacy and safety of RDN in patients who are already on one to three antihypertensive drugs.

Author
EuroPCR 2026 – Coronary revascularisation in patients undergoing TAVI
20 May 2026
Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is an individual participant data meta-analysis of 4 randomised controlled trials...
GLORIOUS - Efficacy of restrictive versus liberal oxygenation or Exenatide in patients undergoing coronary artery bypass grafting or aortic valve replacement – a randomised clinical trial
21 Nov 2024
Edoardo Zancanaro provides his take on the GLORIOUS trial presented by Sebastian Wiberg at AHA 2024 in Chicago.

Author
EuroPCR 2025 – The FAITAVI trial: angiography versus physiology-guided PCI in patients undergoing TAVI – 12-month follow-up data
21 May 2025
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...
Aortic stenosis and coronary artery disease: which should be treated first?
18 Jun 2026
In this review, Henryk Dreger explores the complex interplay between aortic stenosis and coronary artery disease, highlighting the latest evidence on PCI timing and its implications for clinical decision-making.

Author
Transcatheter aortic valve implantation without routine percutaneous coronary intervention: A randomized controlled trial (PRO-TAVI Trial)
29 Mar 2026
Jonathan Curio provides his take on the PRO-TAVI trial presented by Michiel Voskuil at ACC.26 in New Orleans and simultaneously published in The Lancet.

Author
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation
05 Sep 2023
The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...

Author

Author
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.

Author
A randomized, placebo-controlled trial of chronic total occlusion PCI in stable angina - ORBITA-CTO trial
03 Apr 2026
Kalaivani Mahadevan provides an in-depth analysis of the ORBITA-CTO trial: a first-ever randomised, double-blind, placebo-controlled trial evaluating CTO PCI in stable angina patients.
She also interviewed principal investigators Sarosh Khan and John Davies following the LBCT Scientific Session at ACC.26 in New Orleans and simultaneous publication in...

Author

Author

Author
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
02 Sep 2025
Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...

Author